-
Je něco špatně v tomto záznamu ?
Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney
JM. Halimi, P. Sarafidis, M. Azizi, G. Bilo, T. Burkard, M. Bursztyn, M. Camafort, N. Chapman, S. Cottone, T. de Backer, J. Deinum, P. Delmotte, M. Dorobantu, M. Doumas, R. Dusing, B. Duly-Bouhanick, JP. Fauvel, P. Fesler, Z. Gaciong, E....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, multicentrická studie
NLK
Directory of Open Access Journals
od 2022
Taylor & Francis Open Access
od 2022-12-01
Medline Complete (EBSCOhost)
od 1998-04-20
ROAD: Directory of Open Access Scholarly Resources
od 1992
- MeSH
- antagonisté receptorů pro angiotenzin terapeutické užití MeSH
- antihypertenziva terapeutické užití MeSH
- blokátory kalciových kanálů terapeutické užití MeSH
- chronická renální insuficience * komplikace farmakoterapie MeSH
- hypertenze * farmakoterapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- průzkumy a dotazníky MeSH
- společnosti lékařské MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- Geografické názvy
- Evropa MeSH
Objective Real-life management of patients with hypertension and chronic kidney disease (CKD) among European Society of Hypertension Excellence Centres (ESH-ECs) is unclear : we aimed to investigate it. Methods A survey was conducted in 2023. The questionnaire contained 64 questions asking ESH-ECs representatives to estimate how patients with CKD are managed. Results Overall, 88 ESH-ECS representatives from 27 countries participated. According to the responders, renin-angiotensin system (RAS) blockers, calcium-channel blockers and thiazides were often added when these medications were lacking in CKD patients, but physicians were more prone to initiate RAS blockers (90% [interquartile range: 70-95%]) than MRA (20% [10-30%]), SGLT2i (30% [20-50%]) or (GLP1-RA (10% [5-15%]). Despite treatment optimisation, 30% of responders indicated that hypertension remained uncontrolled (30% (15-40%) vs 18% [10%-25%]) in CKD and CKD patients, respectively). Hyperkalemia was the most frequent barrier to initiate RAS blockers, and dosage reduction was considered in 45% of responders when kalaemia was 5.5-5.9 mmol/L. Conclusions RAS blockers are initiated in most ESH-ECS in CKD patients, but MRA and SGLT2i initiations are less frequent. Hyperkalemia was the main barrier for initiation or adequate dosing of RAS blockade, and RAS blockers' dosage reduction was the usual management.
2nd Department of Cardiology Medical School University of Athens ATTIKON Hospital Athens Greece
2nd Department of Internal Medicine St Anne's University Hospital Brno Czech Republic
2nd Prop Department of Internal Medicine Aristotle University Thessaloniki Greece
AP HP Unité d'hypertension artérielle service de médecine interne Hôpital Avicenne Bobigny France
APHP Service d'Hypertension Artérielle Hôpital Européen Georges Pompidou Paris France
Cardiology Department Klinikum Wels Grieskirchen Wels Austria
Cardiovascular Risk and Hypertension Madrid Spain
Cardiovascular Risk Clinic Western General Hospital Edinburgh UK
Center of Preventive Cardiology Armenia Parounak Zelveian Hospital N2 CJSC Yerevan Armenia
Centre of Cardiology North Estonia Medical Centre Tallinn University of Technology Tallinn Estonia
Clinica Medica University Milano Bicocca Milan Italy
Department of Advanced Medical Sciences Federico 2 University of Naples Italy
Department of Cardiology Abdali Hospital Amman Jordan
Department of Cardiology Danderyd University Hospital Corp Stockholm Sweden
Department of Cardiology LAIKO General Hospital Athens Greece
Department of Cardiology Medical University of Graz Graz Austria
Department of Cardiovascular Diseases Internal Medicine University Hospital Ghent Ghent Belgium
Department of Clinical Sciences Lund University Skane University Hospital Malmö Sweden
Department of Heart Disease Haukeland University Hospital Bergen Norway
Department of Internal Medicine 4 Medical University Innsbruck Anichstrasse Innsbruck Austria
Department of Internal Medicine and Cardiology University Hospital Ostrava Czech Republic
Department of Internal Medicine Montpellier University Hospital Montpellier France
Department of Internal Medicine Nephrology Heinrich Heine University Duesseldorf Duesseldorf Germany
Department of Medical Sciences University of Turin Italy
Department of Medicine and Surgery University of Milano Bicocca Milan Italy
Department of Medicine CINTESIS RISE Faculty of Medicine of Porto Portugal
Department of Medicine Radboud University Medical Center Nijmegen the Netherlands
Department of Nephrology and Hypertension Hôpital Ed Herriot Lyon France
Department of Nephrology Cantonal Hospital Graubuenden Chur Switzerland
Department of Nephrology Helsinki University Hospital and University of Helsinki Helsinki Finland
Dept of Nephrology and Hypertension Hypertension Center Hannover Medical School Hannover Germany
Division of Cardiology Izmir Medicana International Hospital Yenisehir Turkey
Division of Medicine Turku University Hospital Turku University Turku Finland
ESH Excellent Center Hypertension LAIKO University Hospital Athens Greece
Faculty of Medicine School of Medicine Hadassah Hebrew University Jerusalem Israel
Faculty of Medicine University of Ostrava Czech Republic
Fakulty of Medicine Masaryk University Brno Czech Republic
Grzegorz Bilo Department of Cardiology Istituto Auxologico Italiano IRCCS Milan Italy
Hypertension Clinic Hadassah Hebrew University Medical Center Mount Scopus Jerusalem
Hypertension Unit Department of Cardiology HELORA University Hospitals Mons Belgium
Hypertension Unit Department of Internal Medicine Hospital Clinic University of Barcelona Spain
Hypertension Unit Dept of Internal Medicine University Hospital of Heraklion Heraklion Greece
Hypertension Unit KAT General Hospital of Attica Greece
INSERM UMR 942 MASCOT Paris 13 Université Paris Nord FCRIN INI CRCT Bobigny France
Internal Medicine Department Hospital Centre of Vila Nova de Gaia Espinho Portugal
Internal Medicine Unit Department of Medicine ESH Excellence Center Unit Italy
Medical Outpatient Department and Hypertension Clinic University Hospital Basel Basel Switzerland
Metropolitan Hospital Piraeus Greece
Peart Rose Clinic Hammersmith Hospital Imperial College Healthcare Trust London UK
PhyMedExp INSERM U1046 CNRS UMR 9214 University of Montpellier Montpellier France
Plava Medical Group Sarajevo Bosnia and Herzegovina
School of Medicine Aristotle University of Thessaloniki Greece
Service d'HTA et Therapeutique CHU Rangueil Toulouse University Toulouse France
Service de Médecine Interne Hôpital Franco Britannique Levallois Perret France
Service de Néphrologie CIC CRB 1404 INSERM EnVi U1096 CHU Rouen France
Service de Néphrologie Hypertension Dialyses Transplantation rénale Hôpital Bretonneau Tours France
Service de Néphrologie transplantation dialyse aphérèses CHU Bordeaux France
South Buda Center Hospital St Imre University Teaching Hospital Budapest Hungary
St George University Medical Center Achrafieh Beirut Lebanon
St Josefs Hospital Cloppenburg Germany
Università degli Studi e IRCCS Ospedale Policlinico San Martino di Genova Italy
Université Paris Cité Department of Cardiology Paris France
University of Palermo Department of Nephrology Palermo Italy
Vascular Risk Unit Internal Medicine Virgen de las Nieves University Hospital Granada Spain
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013276
- 003
- CZ-PrNML
- 005
- 20240905133326.0
- 007
- ta
- 008
- 240725s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/08037051.2024.2368800 $2 doi
- 035 __
- $a (PubMed)38910347
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Halimi, Jean-Michel $u Service de Néphrologie-Hypertension, Dialyses, Transplantation rénale, Hôpital Bretonneau, Tours, France
- 245 10
- $a Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney / $c JM. Halimi, P. Sarafidis, M. Azizi, G. Bilo, T. Burkard, M. Bursztyn, M. Camafort, N. Chapman, S. Cottone, T. de Backer, J. Deinum, P. Delmotte, M. Dorobantu, M. Doumas, R. Dusing, B. Duly-Bouhanick, JP. Fauvel, P. Fesler, Z. Gaciong, E. Gkaliagkousi, D. Gordin, G. Grassi, C. Grassos, D. Guerrot, J. Huart, R. Izzo, F. Jaén Águila, Z. Járai, T. Kahan, I. Kantola, E. Kociánová, F. Limbourg, M. Lopez-Sublet, F. Mallamaci, A. Manolis, M. Marketou, G. Mayer, A. Mazza, I. MacIntyre, JJ. Mourad, ML. Muiesan, E. Nasr, P. Nilsson, A. Oliveras, O. Ormezzano, V. Paixão-Dias, I. Papadakis, D. Papadopoulos, S. Perl, J. Polónia, R. Pontremoli, G. Pucci, NR. Robles, S. Rubin, LM. Ruilope, LC. Rump, S. Saeed, E. Sanidas, R. Sarzani, R. Schmieder, F. Silhol, S. Sokolovic, M. Solbu, M. Soucek, G. Stergiou, I. Sudano, R. Tabbalat, I. Tengiz, H. Triantafyllidi, K. Tsioufis, J. Václavík, M. van der Giet, PV. der Niepen, F. Veglio, R. Venzin, M. Viigimaa, T. Weber, J. Widimsky, G. Wuerzner, P. Zelveian, P. Zebekakis, S. Lueders, A. Persu, R. Kreutz, L. Vogt
- 520 9_
- $a Objective Real-life management of patients with hypertension and chronic kidney disease (CKD) among European Society of Hypertension Excellence Centres (ESH-ECs) is unclear : we aimed to investigate it. Methods A survey was conducted in 2023. The questionnaire contained 64 questions asking ESH-ECs representatives to estimate how patients with CKD are managed. Results Overall, 88 ESH-ECS representatives from 27 countries participated. According to the responders, renin-angiotensin system (RAS) blockers, calcium-channel blockers and thiazides were often added when these medications were lacking in CKD patients, but physicians were more prone to initiate RAS blockers (90% [interquartile range: 70-95%]) than MRA (20% [10-30%]), SGLT2i (30% [20-50%]) or (GLP1-RA (10% [5-15%]). Despite treatment optimisation, 30% of responders indicated that hypertension remained uncontrolled (30% (15-40%) vs 18% [10%-25%]) in CKD and CKD patients, respectively). Hyperkalemia was the most frequent barrier to initiate RAS blockers, and dosage reduction was considered in 45% of responders when kalaemia was 5.5-5.9 mmol/L. Conclusions RAS blockers are initiated in most ESH-ECS in CKD patients, but MRA and SGLT2i initiations are less frequent. Hyperkalemia was the main barrier for initiation or adequate dosing of RAS blockade, and RAS blockers' dosage reduction was the usual management.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a chronická renální insuficience $x komplikace $x farmakoterapie $7 D051436
- 650 12
- $a hypertenze $x farmakoterapie $7 D006973
- 650 _2
- $a antihypertenziva $x terapeutické užití $7 D000959
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a blokátory kalciových kanálů $x terapeutické užití $7 D002121
- 650 _2
- $a společnosti lékařské $7 D012955
- 650 _2
- $a antagonisté receptorů pro angiotenzin $x terapeutické užití $7 D057911
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Sarafidis, Pantelis $u School of Medicine, Aristotle University of Thessaloniki, Greece
- 700 1_
- $a Azizi, Michel $u Université Paris Cité Department of Cardiology, Paris, France $u APHP, Service d'Hypertension Artérielle, Hôpital Européen Georges Pompidou, Paris, France
- 700 1_
- $a Bilo, Grzegorz $u Grzegorz Bilo, Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy $u Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
- 700 1_
- $a Burkard, Thilo $u Medical Outpatient Department and Hypertension Clinic, University Hospital Basel, Basel, Switzerland
- 700 1_
- $a Bursztyn, Michael $u Hypertension Clinic, Hadassah-Hebrew University Medical Center, Mount Scopus, Jerusalem $u Faculty of Medicine, School of Medicine, Hadassah-Hebrew University, Jerusalem, Israel $1 https://orcid.org/0000000172390501
- 700 1_
- $a Camafort, Miguel $u Hypertension Unit, Department of Internal Medicine, Hospital Clinic, University of Barcelona, Spain
- 700 1_
- $a Chapman, Neil $u Peart-Rose Clinic, Hammersmith Hospital, Imperial College Healthcare Trust, London, UK $1 https://orcid.org/0000000313079275
- 700 1_
- $a Cottone, Santina $u PROMISE Department, Nephrology and Dialisys Unit with Hypertension ESH Excellence Centre, University Hospital P.Giaccone, Palermo, Italy $u University of Palermo Department of Nephrology, Palermo, Italy
- 700 1_
- $a de Backer, Tine $u Department of Cardiovascular Diseases, Internal Medicine, University Hospital Ghent, Ghent, Belgium
- 700 1_
- $a Deinum, Jaap $u Department of Medicine, Radboud University Medical Center, Nijmegen, the Netherlands $1 https://orcid.org/0000000324651986
- 700 1_
- $a Delmotte, Philippe $u Hypertension Unit (European Society of Hypertension Excellence Centre), Department of Cardiology, HELORA University Hospitals, Mons, Belgium $1 https://orcid.org/0000000287898225
- 700 1_
- $a Dorobantu, Maria $u Emergency Clinical Hospital of Bucharest Department of Emergency Medicineap: Department of Cardiology, Bucharest, Romania
- 700 1_
- $a Doumas, Michalis $u 2nd Prop Department of Internal Medicine, Aristotle University, Thessaloniki, Greece
- 700 1_
- $a Dusing, Rainer $u Hypertoniezentrum Bonn, Schwerpunktpraxis Kardiologie, Angiologie, Prävention, Rehabilitation, Bonn, Germany
- 700 1_
- $a Duly-Bouhanick, Béatrice $u Service d'HTA et Therapeutique CHU Rangueil, Toulouse University, Toulouse, France $1 https://orcid.org/0000000151628779
- 700 1_
- $a Fauvel, Jean-Pierre $u Department of Nephrology and Hypertension, Hôpital Ed Herriot, Lyon, France
- 700 1_
- $a Fesler, Pierre $u Department of Internal Medicine, Montpellier University Hospital, Montpellier, France $u PhyMedExp, INSERM U1046, CNRS UMR 9214, University of Montpellier, Montpellier, France $1 https://orcid.org/0000000278316545
- 700 1_
- $a Gaciong, Zbigniew $u Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, Warsaw, Poland
- 700 1_
- $a Gkaliagkousi, Eugenia $u 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Greece $1 https://orcid.org/0000000263242475
- 700 1_
- $a Gordin, Daniel $u Department of Nephrology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland $1 https://orcid.org/0000000314948292
- 700 1_
- $a Grassi, Guido $u Clinica Medica, University Milano Bicocca, Milan, Italy
- 700 1_
- $a Grassos, Charalampos $u Hypertension Unit, KAT General Hospital of Attica, Greece
- 700 1_
- $a Guerrot, Dominique $u Service de Néphrologie, CIC-CRB 1404, INSERM EnVi U1096, CHU Rouen, France $1 https://orcid.org/0000000259535785
- 700 1_
- $a Huart, Justine $u Division of Nephrology, University of Liège Hospital (ULg CHU), University of Liège, and Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Cardiovascular Sciences, University of Liège, Liège, Belgium $1 https://orcid.org/0000000254558769
- 700 1_
- $a Izzo, Raffaele $u Department of Advanced Medical Sciences, Federico II University of Naples, Italy $1 https://orcid.org/0000000203082836
- 700 1_
- $a Jaén Águila, Fernando $u Vascular Risk Unit, Internal Medicine, Virgen de las Nieves University Hospital, Granada, Spain
- 700 1_
- $a Járai, Zoltán $u South-Buda Center Hospital, St. Imre University Teaching Hospital, Budapest, Hungary $1 https://orcid.org/0000000306509361
- 700 1_
- $a Kahan, Thomas $u Department of Clinical Sciences, Division of Cardiovascular Medicine, Karolinska Institute, Stockholm, Sweden $u Department of Cardiology, Danderyd University Hospital Corp, Stockholm, Sweden $1 https://orcid.org/0000000199094956
- 700 1_
- $a Kantola, Ilkka $u Division of Medicine, Turku University Hospital, Turku University, Turku, Finland $1 https://orcid.org/000000026228522X
- 700 1_
- $a Kociánová, Eva $u First Department of Internal Medicine - Cardiology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic
- 700 1_
- $a Limbourg, FlorianP $u Dept. of Nephrology and Hypertension, Hypertension Center, Hannover Medical School, Hannover, Germany $1 https://orcid.org/0000000283137226
- 700 1_
- $a Lopez-Sublet, Marilucy $u AP-HP, Unité d'hypertension artérielle, service de médecine interne, Hôpital Avicenne, Bobigny, France $u INSERM UMR 942 MASCOT, Paris 13-Université Paris Nord, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Bobigny, France
- 700 1_
- $a Mallamaci, Francesca $u Grande Ospedale Metropolitano, UOC di Nefrologia abilitata al trapianto renale, CNR Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione Arteriosa, Reggio Calabria, Italy
- 700 1_
- $a Manolis, Athanasios $u Metropolitan Hospital, Piraeus, Greece $1 https://orcid.org/0000000242734489
- 700 1_
- $a Marketou, Maria $u Hypertension Outpatient Clinic, Cardiology Department, Heraklion University General Hospital, Heraklion, Greece
- 700 1_
- $a Mayer, Gert $u Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck Anichstrasse, Innsbruck, Austria $1 https://orcid.org/0000000346051789
- 700 1_
- $a Mazza, Alberto $u Internal Medicine Unit, Department of Medicine, ESH Excellence Center Unit, Italy
- 700 1_
- $a MacIntyre, IainM $u Cardiovascular Risk Clinic, Western General Hospital, Edinburgh, UK $1 https://orcid.org/0000000344203822
- 700 1_
- $a Mourad, Jean-Jacques $u Service de Médecine Interne, Hôpital Franco-Britannique, Levallois-Perret, France
- 700 1_
- $a Muiesan, Maria Lorenza $u Centro Studi Diagnosi e Cura dell'Ipertensione Arteriosa e del Rischio Cardiovascolare (IARC), University of Brescia and ASST Spedali Civili, Italy
- 700 1_
- $a Nasr, Edgar $u St George University Medical Center Achrafieh-Beirut, Lebanon
- 700 1_
- $a Nilsson, Peter $u Department of Clinical Sciences, Lund University, Skane University Hospital, Malmö, Sweden $1 https://orcid.org/0000000256528459
- 700 1_
- $a Oliveras, Anna $u Hypertension and Vascular Risk Unit, Department of Nephrology, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institute), Universitat Pompeu Fabra, Barcelona, Spain $1 https://orcid.org/000000025503545X
- 700 1_
- $a Ormezzano, Olivier $u UF Hypertension et Athérothrombose, Centre Européen d'Excellence en Hypertension Artérielle, Service de Cardiologie, CHU Michallon, Grenoble, France
- 700 1_
- $a Paixão-Dias, Vitor $u Internal Medicine Department, Hospital Centre of Vila Nova de Gaia/Espinho, Portugal $1 https://orcid.org/0000000265212675
- 700 1_
- $a Papadakis, Ioannis $u Hypertension Unit, Dept. of Internal Medicine, University Hospital of Heraklion, Heraklion, Greece $1 https://orcid.org/000000029121296X
- 700 1_
- $a Papadopoulos, Dimitris $u ESH Excellent Center Hypertension, LAIKO University Hospital, Athens, Greece
- 700 1_
- $a Perl, Sabine $u Department of Cardiology, Medical University of Graz, Graz, Austria
- 700 1_
- $a Polónia, Jorge $u Department of Medicine CINTESIS RISE, Faculty of Medicine of Porto, Portugal
- 700 1_
- $a Pontremoli, Roberto $u Università degli Studi e IRCCS Ospedale Policlinico San Martino di Genova, Italy $1 https://orcid.org/000000031238872X
- 700 1_
- $a Pucci, Giacomo $u Department of Medicine and Surgery, University of Perugia, Unit of Internal Medicine - Santa Maria Terni Hospital, Terni, Italy
- 700 1_
- $a Robles, Nicolás Roberto $u Badajoz, Spain $1 https://orcid.org/0000000239993607
- 700 1_
- $a Rubin, Sébastien $u Service de Néphrologie-transplantation-dialyse-aphérèses, CHU Bordeaux, France $1 https://orcid.org/0000000212460712
- 700 1_
- $a Ruilope, Luis Miguel $u Cardiovascular Risk and Hypertension, Madrid, Spain
- 700 1_
- $a Rump, Lars Christian $u Department of Internal Medicine/Nephrology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
- 700 1_
- $a Saeed, Sahrai $u Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
- 700 1_
- $a Sanidas, Elias $u Department of Cardiology, LAIKO General Hospital, Athens, Greece
- 700 1_
- $a Sarzani, Riccardo $u Università Politecnica delle Marche and IRCCS-INRCA Department of Clinical and Molecular Sciences, Ancona, Italy
- 700 1_
- $a Schmieder, Roland $u Department of Nephrology, Hypertension University Hospital Erlangen, Friedrich Alexander University Erlangen/Nürnberg, Germany $1 https://orcid.org/0000000323565883
- 700 1_
- $a Silhol, François $u Service de Médecine Vasculaire et Hypertension Artérielle, Centre de compétence régional des maladies artérielles rares, Centre d'excellence Européen en Hypertension Artérielle 264, rue Saint Pierre, CHU Timone, Marseille, France
- 700 1_
- $a Sokolovic, Sekib $u Plava Medical Group, Sarajevo, Bosnia and Herzegovina
- 700 1_
- $a Solbu, Marit $u University Hospital of North Norway Department of Nephrology cb: Department of Internal Medicine and Cardiology, Tromsø, Norway $1 https://orcid.org/0000000243317548
- 700 1_
- $a Soucek, Miroslav $u 2nd Department of Internal Medicine, St. Anne's University Hospital, Brno, Czech Republic $u Fakulty of Medicine, Masaryk University Brno, Czech Republic
- 700 1_
- $a Stergiou, George $u School of Medicine, Third Department of Medicine, Sotiria Hospital, Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, Athens, Greece $1 https://orcid.org/0000000261320038
- 700 1_
- $a Sudano, Isabella $u University Hospital Zurich University Heart Center, Cardiology and University of Zurich, Zurich, Switzerland
- 700 1_
- $a Tabbalat, Ramzi $u Department of Cardiology, Abdali Hospital, Amman, Jordan $1 https://orcid.org/0000000326289618
- 700 1_
- $a Tengiz, Istemihan $u Division of Cardiology, Izmir Medicana International Hospital, Yenisehir, Turkey
- 700 1_
- $a Triantafyllidi, Helen $u 2nd Department of Cardiology, Medical School, University of Athens, ATTIKON Hospital, Athens, Greece
- 700 1_
- $a Tsioufis, Konstontinos $u 1st Department of Cardiology, National and Kapodistrian University of Athens, Hippocratio Hospital, Greece
- 700 1_
- $a Václavík, Jan $u Department of Internal Medicine and Cardiology, University Hospital Ostrava, Czech Republic $u Faculty of Medicine, University of Ostrava, Czech Republic $1 https://orcid.org/0000000178470967 $7 xx0169228
- 700 1_
- $a van der Giet, Markus $u Medinische Klinik für Nephrologie und internistische Intensivtherapie, Charité - Universitätsmedizin Berlin, Berlin, Germany $1 https://orcid.org/0000000335905451
- 700 1_
- $a der Niepen, Patricia Van $u Departement of Nephrology & Hypertension, Universitair Ziekenhuis Brussel Department of Nephrology and Hypertension, VUB, Belgium $1 https://orcid.org/0000000264011580
- 700 1_
- $a Veglio, Franco $u Department of Medical Sciences, University of Turin, Italy $1 https://orcid.org/0000000266546247
- 700 1_
- $a Venzin, RetoM $u Department of Nephrology, Cantonal Hospital Graubuenden, Chur, Switzerland
- 700 1_
- $a Viigimaa, Margus $u Centre of Cardiology, North Estonia Medical Centre, Tallinn University of Technology, Tallinn, Estonia $1 https://orcid.org/0000000155755978
- 700 1_
- $a Weber, Thomas $u Cardiology Department, Klinikum Wels-Grieskirchen, Wels, Austria $1 https://orcid.org/0000000306170417
- 700 1_
- $a Widimsky, Jiri $u IIIrd Internal Department, Centre for Hypertension, General Faculty Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Wuerzner, Gregoire $u Service de néphrologie et d'hypertension, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland $1 https://orcid.org/0000000264247630
- 700 1_
- $a Zelveian, Parounak $u Center of Preventive Cardiology, Armenia Parounak Zelveian, Hospital N2 CJSC, Yerevan, Armenia $1 https://orcid.org/0000000265136772
- 700 1_
- $a Zebekakis, Pantelis $u Hypertension Unit of the First Department of Medicine, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece
- 700 1_
- $a Lueders, Stephan $u St. Josefs Hospital, Cloppenburg, Germany
- 700 1_
- $a Persu, Alexandre $u Department of Cardiovascular Diseases, Division of Cardiology, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium
- 700 1_
- $a Kreutz, Reinhold $u Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- 700 1_
- $a Vogt, Liffert $u Department of Internal Medicine, Section of Nephrology, Amsterdam University Medical Center, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, the Netherlands
- 773 0_
- $w MED00000810 $t Blood pressure $x 1651-1999 $g Roč. 33, č. 1 (2024), s. 2368800
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38910347 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133320 $b ABA008
- 999 __
- $a ok $b bmc $g 2143228 $s 1225142
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 33 $c 1 $d 2368800 $e 20240623 $i 1651-1999 $m Blood pressure $n Blood Press $x MED00000810
- LZP __
- $a Pubmed-20240725
